These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1144 related articles for article (PubMed ID: 23898)
1. Psychotropic drugs as potential antitumor agents: a selective screening study. Driscoll JS; Melnick NR; Quinn FR; Lomax N; Davignon JP; Ing R; Abott BJ; Congleton G; Dudeck L Cancer Treat Rep; 1978 Jan; 62(1):45-74. PubMed ID: 23898 [TBL] [Abstract][Full Text] [Related]
2. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
3. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
4. [Psychotropic drugs and new 1,5-benzodiazepine analogs as antitumor agents]. Werner W; Wohlrabe K; Gutsche W; Jungstand W; Römer W Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):637-42. PubMed ID: 6172326 [No Abstract] [Full Text] [Related]
5. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems. Flora KP; van't Riet B; Wampler GL Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155 [TBL] [Abstract][Full Text] [Related]
7. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice. Dawson KM Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
9. Phenylthioalkylamines in experimental tumor treatment in mice. DiStefano V; Evans I; Myers-Robfogel M; Estes J; Godleski SA J Natl Cancer Inst; 1983 Dec; 71(6):1289-93. PubMed ID: 6581362 [TBL] [Abstract][Full Text] [Related]
10. Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin. Neil GL; Kuentzel SL; McGovren JP Cancer Treat Rep; 1979; 63(11-12):1971-8. PubMed ID: 526931 [TBL] [Abstract][Full Text] [Related]
11. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778 [TBL] [Abstract][Full Text] [Related]
12. Indicine-N-oxide: the antitumor principle of Heliotropium indicum. Kugelman M; Liu WC; Axelrod M; McBride TJ; Rao KV Lloydia; 1976; 39(2-3):125-8. PubMed ID: 948236 [TBL] [Abstract][Full Text] [Related]
13. Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy. Staquet MJ; Byar DP; Green SB; Rozencweig M Cancer Treat Rep; 1983 Sep; 67(9):753-65. PubMed ID: 6883351 [TBL] [Abstract][Full Text] [Related]
14. [Models of preclinical studies of anthracyclines]. Fizames C Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611 [TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect of a benzoylphenylurea derivative HO-221]. Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars. Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170 [TBL] [Abstract][Full Text] [Related]
17. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity. Finch RA; Shyam K; Penketh PG; Sartorelli AC Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484 [TBL] [Abstract][Full Text] [Related]
18. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. Wallace RE; Murdock KC; Angier RB; Durr FE Cancer Res; 1979 May; 39(5):1570-4. PubMed ID: 427798 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of cis-dichlorodiammineplatinum(II). Wolpert-DeFilippes MK Cancer Treat Rep; 1979; 63(9-10):1453-8. PubMed ID: 498146 [TBL] [Abstract][Full Text] [Related]
20. Alkylphosphonium salts as a new class of antitumor agents. Sanyal U; Chatterjee RS; Das SK; Chakraborti SK Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]